Strain-dependent disease progression and necrotizing granuloma formation induced by virulent Mycobacterium avium complex strains in a murine model
Haruka HikichiiD, Shiho Omori, Hajime Nakamura, Shintaro SetoiD, Koji FuruuchiiD, Kozo MorimotoiD, Minako HijikataiD, Naoto KeichoiD
Abstract
Mycobacterium avium complex (MAC) is the leading cause of non-tuberculous mycobacterial pulmonary disease (NTM-PD), a chronic infection with a heterogeneous clinical course. Although murine models of MAC-PD have been developed, reproducing the key features of progressive human disease, including diverse pathological features and therapeutic sensitivities, remains challenging. In this study, we evaluated five clinical MAC strains, including a newly identified highly virulent isolate, NBRC112750, in immunocompetent BALB/c mice. Among these, FKJ-1 and NBRC112750 induced progressive pulmonary infection with increasing bacterial burdens and extensive lung involvement by 25 weeks post-infection. Notably, both strains led to the formation of necrotizing granulomas resembling those observed in M. tuberculosis-infected C3HeB/FeJ mice. These lesions featured neutrophilic infiltration, foamy macrophages, and collagen encapsulation. Using FKJ-1 strain, we also established an inhalation infection model, in which low-dose exposure reproduced necrotizing granulomas. Despite in vitro drug susceptibility, FKJ-1 infection exhibited poor response to standard therapy, highlighting strain-dependent variability in treatment efficacy. These findings establish a murine model that reflects both key pathological and therapeutic aspects of MAC-PD and provides a valuable platform for investigating MAC pathogenesis and evaluating novel therapies.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- FWCI
- 9.37
- Field percentile
- top 3%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Clinical isolates of Mycobacterium avium complex reveal an M. intracellulare-associated IL-17/neutrophilic pulmonary immune program in a murine disease model
Shintaro Seto, Koji Furuuchi, … Naoto Keicho·mSpherePeer-reviewed·Sep 21, 2026
- Dissemination and progression of pulmonary Mycobacterium avium infection in mouse model are associated with type 2 macrophage activation
R. Rosenbloom, I. Gavrish, … N. A. Crossland·bioRxiv·Jun 23, 2021
- Selected clinical strains of Mycobacterium avium unlock in vivo models for NTM drug discovery programs
Tine Van Win, Wannes Brangers, … Emmanuel André·bioRxiv·Jul 14, 2026
- A Marmoset Model for Mycobacterium avium Complex Pulmonary Disease
J. Peters, D. J. Maselli, … D. Griffith·bioRxiv·Nov 15, 2021
- The Role of Biofilms, Bacterial Phenotypes, and Innate Immune Response in Mycobacterium avium Colonization to Infection
Catherine Weathered, Kelly M. Pennington, … Elsje Pienaar·Journal of Theoretical BiologyPeer-reviewed·Oct 28, 2021
- Regimen comprising clarithromycin, clofazimine and bedaquiline is more efficacious than monotherapy in a mouse model of chronic Mycobacterium avium lung infection
Binayak Rimal, Ruth A. Howe, … Gyanu Lamichhane·Antimicrobial Agents and ChemotherapyPeer-reviewed·Mar 14, 2025